Strategies For The Biotech Surge
As the race for a coronavirus vaccine heats up, biotech stocks are on fire. And traders are sharing their strategies for – and best bets… Read More »Strategies For The Biotech Surge
As the race for a coronavirus vaccine heats up, biotech stocks are on fire. And traders are sharing their strategies for – and best bets… Read More »Strategies For The Biotech Surge
Many dividends have become casualties of the COVID-19 pandemic, with more than 175 public companies having reduced their payouts by at least 50%. Fortunately for… Read More »5 Over 5%: Dividend Stocks With Attractive – And Sustainable – Yields
Among the strategies companies have been using to improve their liquidity position in these difficult times is suspending – or cutting – dividend payments. But… Read More »4 Stocks Bucking The Coronavirus Dividend Trend
Nobody knows with any certainty how long it will take to have a safe and effective vaccine for COVID-19. And nobody knows with any certainty… Read More »A Basket Full Of COVID-19 Vaccine Stocks
Pharmaceutical giant AbbVie has weathered the COVID-19 storm relatively well, with its first-quarter revenue and earnings per share both coming in ahead of analyst estimates.… Read More »What About AbbVie?
After a period of extreme volatility, stocks just experienced their best month in three decades. UBS believes that upward trend is likely to continue –… Read More »After Stocks’ Best Month In Decades, Onwards And Upwards?
One positive effect of COVID-19? It has created a situation where high-quality preferred stocks – and their generous yields – are available at some of… Read More »The Pandemic Has Made Preferreds Even More Attractive